Harvest Investment Services’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-41,144
Closed -$22K 367
2024
Q4
$22K Buy
+41,144
New +$28.7K 0.01% 290
2023
Q3
Sell
-44,572
Closed -$484K 208
2023
Q2
$484K Buy
+44,572
New +$382K 0.28% 102

Harvest Investment Services's MRNS Position: Q1 2025 in Review

Harvest Investment Services sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 41,144 shares — an estimated $22K sold.

Harvest Investment Services first reported a position in MRNS in Q2 2023 and held it in 2 quarters. The position peaked at $484K in Q2 2023. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

  • Harvest Investment Services reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
  • Harvest Investment Services sold 41,144 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $22K.
  • Harvest Investment Services first reported a position in Marinus Pharmaceuticals, Inc in Q2 2023 and held it in 2 quarters.
  • Harvest Investment Services's Marinus Pharmaceuticals, Inc position peaked at $484K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Harvest Investment Services's 13F filing for Q1 2025, filed 15 May 2025.